@article{23b47535e98245c6a44b616f98b0eb0e,
title = "Reply to Gan et al., to Calzetta et al., and to Poor",
author = "\{Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (The ENHANCE Trials)\} and Antonio Anzueto and Barjaktarevic, \{Igor Z.\} and Siler, \{Thomas M.\} and Tara Rheault and Thomas Bengtsson and Kathleen Rickard and Frank Sciurba",
year = "2024",
month = jan,
day = "15",
doi = "10.1164/rccm.202309-1657LE",
language = "English (US)",
volume = "209",
pages = "226--228",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",
}